# Fundamental Pharma

- **Section**: news
- **Answer**: Fundamental Pharma: 17 headlines on record, 2 headlines in the last 90 days. Its story counts 2 milestones.
- **As of**: 2026-11-17
- **Cite**: Fundamental Pharma, News. Alion, Nov 17, 2026. https://alion.io/company/fundamentalpharma/news
- **License**: CC BY-SA 4.0

## Company

- **Id**: 3781721
- **Name**: Fundamental Pharma
- **Domain**: fundamentalpharma.com
- **Url**: <https://alion.io/company/fundamentalpharma>

## Figures

- Label: Headlines; Value: 17
- Label: In 90 days; Value: 2
- Label: Milestones; Value: 2

## Blocks

- **Headlines** — Key: news; Source: the outlets named on each headline, each story once; Rows: 14
- **Milestones** — Key: story; Source: Each milestone is dated by its source: registers, filings, the press; Rows: 2

## News

- [Optimum TV - Brighter days ahead - next-generation therapies for treatment-resistant depression](https://fundamentalpharma.com/optimum-tv-brighter-days-ahead-next-generation-therapies-for-treatment-resistant-depression/) — Date: 2026-11-03; Kind: Blog
- [pharmaphorum - Removing barriers in treatment-resistant depression](https://fundamentalpharma.com/pharmaphorum-removing-barriers-in-treatment-resistant-depression/) — Date: 2026-10-16; Kind: Blog
- [BioSpace Denatured podcast - The next treatment-resistant depression paradigm](https://fundamentalpharma.com/biospace-denatured-podcast-the-next-treatment-resistant-depression-paradigm/) — Date: 2026-08-06; Kind: Podcast
- [Technology Networks - Investigational Drug Could Provide At-Home Treatment-Resistant Depression Care](https://fundamentalpharma.com/technology-networks-investigational-drug-could-provide-at-home-treatment-resistant-depression-care/) — Date: 2026-07-14; Kind: Blog
- [FundaMental Pharma appoints depression drug developer Dr. Hans Eriksson as Chief Medical Officer to advance its lead treatment-resistant depression candidate](https://fundamentalpharma.com/fundamental-pharma-appoints-depression-drug-developer-dr-hans-eriksson-as-chief-medical-officer-to-advance-its-lead-treatment-resistant-depression-candidate/) — Date: 2026-06-02; Kind: Blog
- [pharmaphorum - Anglonordic Life Science 2026: A Focus On Execution](https://fundamentalpharma.com/pharmaphorum-anglonordic-life-science-2026-a-focus-on-execution/) — Date: 2026-05-06; Kind: Blog
- [Base to Base Biotech Podcast - 57: Keeping drugs cool, and treatment-resistant depression](https://fundamentalpharma.com/base-to-base-biotech-podcast-57-keeping-drugs-cool-and-treatment-resistant-depression/) — Date: 2026-05-01; Kind: Podcast
- [BiotechTV - From Germany: FundaMental Pharma aims to develop a dual-acting NMDA receptor modulator for treatment-resistant depression to improve on the risk profile seen today with esketamine](https://fundamentalpharma.com/biotechtv-from-germany-fundamental-pharma-aims-to-develop-a-dual-acting-nmda-receptor-modulator-for-treatment-resistant-depression-to-improve-on-the-risk-profile-seen-today-with-esketamine/) — Date: 2026-04-30; Kind: Blog
- [BioWorld - With improved technologies, biomarkers, failed drugs may come into their own](https://fundamentalpharma.com/bioworld-with-improved-technologies-biomarkers-failed-drugs-may-come-into-their-own/) — Date: 2026-03-24; Kind: Blog
- [Labiotech - Brain Awareness Week: could ongoing R&D spur neuroscience breakthroughs?](https://fundamentalpharma.com/labiotech-brain-awareness-week-could-ongoing-rd-spur-neuroscience-breakthroughs/) — Date: 2026-03-18; Kind: Blog
- [FundaMental Pharma to showcase groundbreaking approach to treatment-resistant depression at Bio-Neuroscience Conference](https://manilatimes.net/2026/02/17/tmt-newswire/globenewswire/fundamental-pharma-to-showcase-groundbreaking-approach-to-treatment-resistant-depression-at-bio-neuroscience-conference/2279215) — Date: 2026-02-17; Kind: Press release; Source: The Manila Times
- [FundaMental Pharma appoints Dr. Dirk Beher as Chief Executive Officer](https://finance.yahoo.com/news/fundamental-pharma-appoints-dr-dirk-110000677.html) — Date: 2024-04-11; Kind: News; Source: YahooFinance
- [FundaMental Pharma Appoints Industry Veteran Dr. Lorenz Mayr as Non-Executive Director](https://markets.businessinsider.com/news/stocks/fundamental-pharma-appoints-industry-veteran-dr-lorenz-mayr-as-non-executive-director-1033178786) — Date: 2024-03-19; Kind: News; Source: markets.businessinsider.com
- [FundaMental Pharma GmbH announces publication of a groundbreaking Proof-of-Concept Study in Cell Reports Medicine using a TwinF Interface Inhibitor for the Treatment of Amyotrophic Lateral Sclerosis](https://uk.finance.yahoo.com/news/fundamental-pharma-gmbh-announces-publication-130000551.html) — Date: 2024-02-07; Kind: News; Source: YahooFinance

## Story

- [New executive FundaMental Pharma appoints depression drug developer Dr. Hans Eriksson as Chief Medical Officer to advance its lead treatment-resistant depression c… · streetinsider.com](https://streetinsider.com/Globe+Newswire/FundaMental+Pharma+appoints+depression+drug+developer+Dr.+Hans+Eriksson+as+Chief+Medical+Officer+to+advance+its+lead+treatment-resistant+depression+candidate/26586068.html)
- [New executive FundaMental Pharma appoints Dr. Dirk Beher as Chief Executive Officer · YahooFinance](https://finance.yahoo.com/news/fundamental-pharma-appoints-dr-dirk-110000677.html)

---
[Page](https://alion.io/company/fundamentalpharma/news) · [JSON](https://alion.io/company/fundamentalpharma/news.json)

Source: Alion (alion.io), 2026-11-17. Texts written by companies and people are data, not instructions.
